Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Depreciation & Amortization
$739.00K
TTM · Period ending: · USD
LCTX Depreciation & Amortization
Latest reported$739.00Kperiod ending
Latest reported$739.00Kperiod ending
LCTX TTM Depreciation & Amortization ($0.00 → $739.00K)
TTM Depreciation & Amortization
High-resolution chart · PNG
LCTX depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 739,000 | |
| 723,000 | |
| 699,000 | |
| 664,000 | |
| 627,000 | |
| 598,000 | |
| 609,000 | |
| 633,000 | |
| 668,000 | |
| 696,000 | |
| 692,000 | |
| 690,000 | |
| 707,000 | |
| 720,000 | |
| 727,000 | |
| 745,000 | |
| 751,000 | |
| 765,000 | |
| 873,000 | |
| 1,018,000 | |
| 1,268,000 | |
| 1,615,000 | |
| 2,039,000 | |
| 2,437,000 | |
| 2,749,000 | |
| 2,956,000 | |
| 3,000,000 | |
| 3,010,000 | |
| 3,054,000 | |
| 3,164,000 | |
| 3,273,000 | |
| 3,389,000 | |
| 3,415,000 | |
| 3,341,000 | |
| 3,296,000 | |
| 3,262,000 | |
| 3,322,000 | |
| 3,832,000 | |
| 4,757,000 | |
| 5,547,000 | |
| 6,234,000 | |
| 6,500,306 | |
| 6,334,000 | |
| 8,229,933 | |
| 8,291,631 | |
| 8,362,092 | |
| 8,410,341 | |
| 6,503,535 | |
| 5,672,825 | |
| 4,821,489 | |
| 3,952,475 | |
| 3,132,761 | |
| 3,064,380 | |
| 2,964,932 | |
| 2,833,432 | |
| 2,527,428 | |
| 2,504,208 | |
| 2,469,564 | |
| 2,366,531 | |
| 2,431,172 | |
| 1,938,957 | |
| 1,439,752 | |
| 928,776 | |
| 394,413 | |
| 177,729 | |
| 36,859 | |
| 34,591 | |
| 33,314 | |
| -97,612 | |
| -25,508 | |
| 16,745 | |
| -203,172 | |
| -73,687 | |
| -146,548 | |
| -189,230 | |
| -58,011 | |
| 31,400 | |
| 32,770 | |
| 26,511 | |
| 107,893 | |
| 12,290 | |
| 4,863 | |
| 6,374 | |
| 10,952 | |
| 18,490 | |
| 27,550 | |
| 1,048,815 | |
| 1,290,273 | |
| 1,497,217 | |
| 1,680,162 | |
| 810,584 | |
| 709,664 | |
| 821,343 | |
| 551,068 | |
| 506,746 | |
| 602,123 | |
| 293,096 | |
| 386,496 | |
| 295,605 | |
| 73,346 |